43 related articles for article (PubMed ID: 31479743)
21. Investigating the effect of an identified mutation within a critical site of PAS domain of WalK protein in a vancomycin-intermediate resistant Staphylococcus aureus by computational approaches.
Baseri N; Najar-Peerayeh S; Bakhshi B
BMC Microbiol; 2021 Sep; 21(1):240. PubMed ID: 34474665
[TBL] [Abstract][Full Text] [Related]
22. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
[TBL] [Abstract][Full Text] [Related]
23. β-Lactams against the Fortress of the Gram-Positive
Fisher JF; Mobashery S
Chem Rev; 2021 Mar; 121(6):3412-3463. PubMed ID: 33373523
[TBL] [Abstract][Full Text] [Related]
24. More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin.
Gray DA; Wenzel M
Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31947747
[TBL] [Abstract][Full Text] [Related]
25. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
[TBL] [Abstract][Full Text] [Related]
26. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
[TBL] [Abstract][Full Text] [Related]
27. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
Bayer AS; Mishra NN; Sakoulas G; Nonejuie P; Nast CC; Pogliano J; Chen KT; Ellison SN; Yeaman MR; Yang SJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7462-7. PubMed ID: 25288091
[TBL] [Abstract][Full Text] [Related]
29. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
[TBL] [Abstract][Full Text] [Related]
30. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
Yin Y; Chen H; Li S; Gao H; Sun S; Li H; Wang R; Jin L; Liu Y; Wang H
Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
[TBL] [Abstract][Full Text] [Related]
31. MprF-mediated daptomycin resistance.
Ernst CM; Peschel A
Int J Med Microbiol; 2019 Jul; 309(5):359-363. PubMed ID: 31182276
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of resistance to daptomycin in Staphylococcus aureus.
Gómez Casanova N; Siller Ruiz M; Muñoz Bellido JL
Rev Esp Quimioter; 2017 Dec; 30(6):391-396. PubMed ID: 29082727
[TBL] [Abstract][Full Text] [Related]
33. Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus.
Boucher HW; Sakoulas G
Clin Infect Dis; 2007 Sep; 45(5):601-8. PubMed ID: 17682996
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
